epirubicin has been researched along with Eccrine Porocarcinoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Endo, Y; Irie, H; Ishida, Y; Kabashima, K; Kaku, Y; Komatsu-Fujii, T; Nomura, T; Otsuka, A; Tahara, J; Yamamura, K | 1 |
| Amagai, M; Fukuda, K; Fukuyama, M; Funakoshi, T; Kakuta, R; Masugi, Y; Nakamura, Y; Sato, M; Tanese, K | 1 |
2 other study(ies) available for epirubicin and Eccrine Porocarcinoma
| Article | Year |
|---|---|
A case of metastatic eccrine porocarcinoma without actionable mutations treated with carboplatin and epirubicin chemotherapy.
Topics: Aged; Antineoplastic Agents; Carboplatin; Eccrine Porocarcinoma; Epirubicin; Humans; Male; Mutation; Treatment Outcome | 2021 |
Metastatic eccrine porocarcinoma successfully treated with carboplatin and epirubicin chemotherapy.
Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Eccrine Porocarcinoma; Epirubicin; Humans; Male; Sweat Gland Neoplasms | 2015 |